The Immunodeficiency Therapeutics Market is being driven by rising prevalence of immunological illnesses in children

  

Market Overview

During the forecast period, the Primary Immunodeficiency Therapeutics Market is expected to grow at a CAGR of 6.1 percent. Primary immunodeficiencies are a group of illnesses in which a component of the immune system (mostly cells and proteins) is missing or not functioning properly. According to studies, there are about 300 different types of  immunodeficiency diseases (PIDD). White blood cells generated in the bone marrow make up the immune system, which protects and defends against foreign invaders such as bacteria, fungus, and germs.


Antibodies and complement are proteins produced in reaction to infection or immunisation, and they aid in the fight against infection and plays a protective role in the immune system. Different types of cells or proteins are absent or do not function in the most prevalent  immunodeficiency illnesses, resulting in severe infections and/or infections that are unusually difficult to cure. Infections can affect the respiratory system, the brain and spinal cord, the ears, the skin, and the urinary and gastrointestinal tracts.  immunodeficiency illnesses can affect a single organ, gland, cell, or tissue, or they can affect several organs, glands, cells, and tissues. Some  immunodeficiency illnesses, for example, have heart abnormalities.

Transplantation, bone marrow transplantation, stem cell transplantation, immunoglobulin replacement therapy, antimicrobial therapy, and ways to manage basic immunodeficiency illnesses are some of the treatment options for  immunodeficiency diseases. In some cases of  immunodeficiency illness, gene therapy has been successful.  immunodeficiency disease therapy research is making significant progress, advancing treatment options and enhancing the quality of life for the majority of people living with these complex diseases.

More than 200 different types of  immunodeficiency illnesses afflict about 500,000 people in the United States, according to the National Institute of Allergy and Infectious Diseases, and these rare hereditary diseases can be severe, chronic, and expensive. Furthermore, severe combined immunodeficiency (SCID) is a rare genetic illness that affects one out of every 30,000 babies, according to the California Institute for Regenerative Medicine.

 

The Immunodeficiency Therapeutics Market is being driven by rising prevalence of immunological illnesses in children and technical breakthroughs in gene therapy.

Key Market Trends

In the  Immunodeficiency Therapeutics Market, the gene therapy segment is expected to hold a significant market share.

Genetic diseases cause the majority of primary immunodeficiencies. For individuals with severe forms of  immunodeficiency disorders, gene therapy is a life-saving option. Gene therapy has already been utilised to treat X-linked SCID, SCID secondary to adenosine deaminase (ADA) deficiency, CGD, and WAS, among other primary immunodeficiencies. According to the Immune Deficiency Foundation, common variable immune deficiency (CVID) is a prevalent form of  immunodeficiency that affects roughly one out of every 25,000 people. Furthermore, because the immune system matures slowly and the diagnosis of CVID is often not made until after the age of four years, roughly 20% of patients display symptoms of CVID disease or are discovered to be immunodeficient in childhood.

The gene therapy segment of the immunodeficiency therapeutics market has a significant market share and is expected to maintain this trend over the forecast period, owing to the promising results of recent clinical trials. Gene therapies are likely to become standard of care for a number of devastating diseases in the coming years.

The primary driving drivers in the gene therapy segment are the rising rates of immunological disorders in children and technological breakthroughs in gene therapy.

 

Comments

Post a Comment

Popular posts from this blog

One of the primary factors driving the Worldwide Frosting and Icing Market is the rising demand for cakes and pastries.

Image
  Market Dynamics The increased demand for cakes and pastries is one of the key reasons driving the global frosting and icing market . According to Agriculture and Agri-Food Canada, the value of cakes sold in the United Kingdom increased by an average of 2% every year from 2012 to 2017, outpacing the CAGR by 1.5 percent (2007-2012). Furthermore, an increase in the number of bakeries as a result of increased urbanisation and rising income, which leads to a burgeoning food sector, is fueling the expansion of the frosting and icing market. In 2015, India's food processing business was valued at US$ 258 billion, according to the India Brand Equity Foundation (IBEF), ranking fifth in terms of consumption, output, and exports. Health issues, such as increased obesity, are, however, restraining market growth. In 2017, 36.5 percent of adults in the United States were obese, according to the Centers for Disease Control and Prevention (CDC), which impeded market expansion. To tackle this, a ...
Read more

Orthopedic Power Tools Market predicted to be growing at a CAGR of 3.50 percent over the forecast period (2020-2027)

Image
Various orthopaedic illnesses in the musculoskeletal systems, such as musculoskeletal trauma, spine diseases, musculoskeletal injuries, and infections, are treated by orthopaedics. Orthopedic power tools are lightweight, user-friendly, and easy to handle when performing orthopaedic surgery when compared to traditional heavy orthopaedic tools. Electric powered orthopaedic tools, battery operated power systems, and pneumatic power tools are the three types of orthopaedic power tools. In 2020, the global orthopaedic power tools market is predicted to be worth US$ 943.8 million, growing at a CAGR of 3.50 percent over the forecast period (2020-2027). One of the reasons predicted to drive market expansion during the forecast period is the rising frequency of spinal injuries. According to a report issued by the National Spinal Cord Injury Statistical Center in 2018, the incidence of spinal cord injury in the United States is roughly 54 instances per one million individuals, with around 17,70...
Read more

The Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Market will continue to increase as the number of ambulatory individuals seeking treatment for skin and skin structure infections rises

Image
Acute Bacterial Skin and Skin Structure Infections (ABSSSI) are infections of the epidermis, dermis, and subcutaneous tissues that affect the skin and soft tissues. ABSSSI is defined by the US FDA as lesions having cellulitis/erysipelas, wound infections, and large cutaneous abscesses with a surface area of at least 75 cm2. ABSSSI is caused by pathogens such as Methicillin-sensitive Staphylococcus aureus (MSSA), Methicillin-resistant Staphylococcus aureus (MRSA), Beta-hemolytic Streptococcus, E. coli, Enterococcus faecalis, and Pseudomonas aeruginosa. The rising incidence of drug-resistant strains, particularly in Staphylococcus spp. and Enterococcus spp., makes this infection challenging to treat. The ABSSSI market is predicted to grow at a steady pace, thanks to an increasing number of patients suffering from these conditions and a significant number of pipeline treatments expected to be authorised during the forecast period. Acute Bacterial Skin and Skin Structure Infections (ABSSSI...
Read more